BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4115589)

  • 1. Cyclophosphamide in minimal-change nephrotic syndrome.
    Uldall PR; Feest TG; Morley AR; Tomlinson BE; Kerr DN
    Lancet; 1972 Sep; 2(7776):537-8. PubMed ID: 4115589
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclophosphamide therapy in adults with minimal-change nephrotic syndrome.
    Uldall PR; Feest TG; Morley AR; Tomlinson BE; Kerr DN
    Lancet; 1972 Jun; 1(7763):1250-3. PubMed ID: 4113514
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term stability of remission in nephrotic syndrome after treatment with cyclophosphamide.
    Cameron JS; Chantler C; Ogg CS; White RH
    Br Med J; 1974 Oct; 4(5935):7-11. PubMed ID: 4425844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up of cyclophosphamide therapy in frequent relapsing minimal lesion nephrotic syndrome.
    Chiu J; Drummond KN
    J Pediatr; 1974 Jun; 84(6):825-30. PubMed ID: 4855503
    [No Abstract]   [Full Text] [Related]  

  • 5. Short-term cyclophosphamide in corticosteroid treated childhood nephrosis.
    Sheth KJ; Liu CC; Good TA
    Wis Med J; 1974 May; 73(5):S55-60. PubMed ID: 4830366
    [No Abstract]   [Full Text] [Related]  

  • 6. [Results of cyclophosphamide treatment of primary nephrotic syndrome in children].
    Starkiewiczowa J; Fydryk J; Lupa B
    Pediatr Pol; 1975 Jan; 50(1):31-6. PubMed ID: 1110844
    [No Abstract]   [Full Text] [Related]  

  • 7. Cyclophosphamide in the treatment of adult nephrotic syndrome.
    Gulati PD; Rizvi SN; Ajmani SK; Bhasin RC; Vaishnava H
    J Assoc Physicians India; 1973 Jan; 21(1):23-9. PubMed ID: 4792697
    [No Abstract]   [Full Text] [Related]  

  • 8. Proceedings: Long-term stability of remission in the nephrotic syndrome after treatment with cyclophosphamide.
    Chantler C; Cameron JS; White RH; Ogg CS
    Arch Dis Child; 1974 Oct; 49(10):823. PubMed ID: 4429383
    [No Abstract]   [Full Text] [Related]  

  • 9. Cyclophosphamide alone in the treatment of adult patients with minimal change glomerulonephritis.
    Al-Khader AA; Lien JW; Aber GM
    Clin Nephrol; 1979 Jan; 11(1):26-30. PubMed ID: 428152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective, controlled trial of cyclophosphamide therapy in children with nephrotic syndrome. Report of the International study of Kidney Disease in Children.
    Lancet; 1974 Aug; 2(7878):423-7. PubMed ID: 4137139
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapeutic and toxic effects observed with different dosage programs of cyclophosphamide in treatment of steroid-responsive but frequently relapsing nephrotic syndrome.
    McCrory WW; Shibuya M; Lu WH; Lewy JE
    J Pediatr; 1973 Apr; 82(4):614-8. PubMed ID: 4698338
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term assessment of cyclophosphamide therapy for nephrosis in children.
    McDonald J; Murphy AV; Arneil GC
    Lancet; 1974 Oct; 2(7887):980-2. PubMed ID: 4138088
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclophosphamide in the treatment of childhood nephrotic syndrome.
    Wiggelinkhuizen J; McDonald R; Kaschula RO
    S Afr Med J; 1972 Sep; 46(39):1417-23. PubMed ID: 4642675
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of cyclophosphamide and corticoids in the treatment of nephrotic syndrome: controlled study].
    Rocha H; Vaccaro Torres CE; Lessa I; Azevêdo Vinhaes L
    Rev Bras Pesqui Med Biol; 1972; 5(1-2):21-8. PubMed ID: 4680451
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclophosphamide treatment in steroid-sensitive nephrotic syndrome of childhood.
    Barratt TM; Bercowsky A; Osofsky SG; Soothill JF
    Lancet; 1975 Jan; 1(7898):55-8. PubMed ID: 46019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experiences with cytotoxic drugs in therapy of the nephrotic syndrome].
    Brandis M; Krohn HP; Hanke K; Brodehl J
    Monatsschr Kinderheilkd (1902); 1977 May; 125(5):566-8. PubMed ID: 876240
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment with tacrolimus and prednisolone is preferable to intravenous cyclophosphamide as the initial therapy for children with steroid-resistant nephrotic syndrome.
    Gulati A; Sinha A; Gupta A; Kanitkar M; Sreenivas V; Sharma J; Mantan M; Agarwal I; Dinda AK; Hari P; Bagga A
    Kidney Int; 2012 Nov; 82(10):1130-5. PubMed ID: 22763815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclophosphamide in the treatment of idiopathic nephrotic syndrome.
    Pennisi AJ; Grushkin CM; Lieberman E
    Pediatrics; 1976 Jun; 57(6):948-51. PubMed ID: 934751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alkylating agents in the treatment of nephrotic syndrome.
    West CD
    Perspect Nephrol Hypertens; 1973; 1 Pt 1():199-210. PubMed ID: 4620919
    [No Abstract]   [Full Text] [Related]  

  • 20. Cytostatic treatment of nephrotic syndrome in children.
    Miltényi M; Marosvári I; Román H; Visy M; Beregi E; Szepesházi K
    Acta Paediatr Acad Sci Hung; 1970; 11(3):263-76. PubMed ID: 5525401
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.